Citrine Global

A plant-based wellness and pharma solutions company in Israel, focusing on developing products to enhance quality of life and balance side effects.

Venture Capital Active Herzliya, Israel Est. 2010
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Citrine Global Corp. operates as a plant-based wellness and pharma solutions company in Israel. The company focuses on developing plant-based products to enhance quality of life and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. It offers SmokLy sprays for cannabis users and tobacco smokers and DryLess sprays for adults with constant dry mouth. Citrine Global is also building the Green Vision Center, a production and innovation center for plant-based wellness & pharma products. The company has a dual-nation structure, combining a U.S. parent company with Israeli subsidiaries, including CTGL Citrine Global Israel Ltd. and SkyTech Orion Ltd. Citrine Global, through its subsidiary SkyTech Orion Ltd., is establishing the SkyTech Center in Yeruham, Israel, as a national hub for UAV and military drone defense solutions.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Citrine Global's primary focus as an investor?
Citrine Global positions itself as a powerhouse for high-growth technology companies.
Which sector does Citrine Global primarily invest in?
Citrine Global has shown a focus on the Health Tech & Life Sciences sector, with one investment in this area.
Can you name a notable company in Citrine Global's portfolio?
One notable company in Citrine Global's portfolio is Nanomedic Technologies, which develops a portable wound treatment system.
When did Citrine Global make its most recent recorded investment?
Citrine Global's most recent recorded investment was in June 2020.
What was the funding stage of Citrine Global's investment in Nanomedic Technologies?
Citrine Global participated in the Series B funding round for Nanomedic Technologies.
What is the typical investment range for Citrine Global?
Citrine Global's investment range is typically between $2.2M and $2.2M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal nameCitrine Global Corp.
Founded2010